🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Peru's foreign minister resigns over coronavirus vaccine scandal

Published 02/14/2021, 09:58 PM
Updated 02/14/2021, 10:00 PM
SHTDY
-

LIMA (Reuters) - Peruvian Foreign Minister Elizabeth Astete said on Sunday night that she resigned after acknowledging she received a dose of the coronavirus vaccine from China's Sinopharm, outside of clinical trials and before the national immunization program began.

Just a day earlier, President Francisco Sagasti said he accepted the resignation of Health Minister Pilar Mazzetti due to a scandal over former President Martin Vizcarra having also received an early vaccination.

Vizcarra, who was ousted by Congress in November over corruption allegations, has said he did not jump the line to receive the vaccination, but rather that he got it as part of a trial. Local media questioned that explanation.

Astete, who had held her post since November, said she was inoculated on Jan. 22 after receiving an offer from the Peruvian university Cayetano Heredia, in charge of the trials, to receive the Sinopharm Group Co (OTC:SHTDY) Ltd vaccine from a "remnant lot" of the tests.

"I am aware of the serious mistake I made, which is why I decided not to receive the second dose," she said through Twitter. "For the reasons stated, I have presented my letter of resignation to the president."

The government announced in early January an agreement with Sinopharm to purchase up to 38 million doses of the vaccine.

The first batch of 300,000 vaccines arrived a week ago and the immunization program against COVID-19 began on Tuesday with the application of doses to healthcare workers who are the most exposed to the disease. Sagasti was one of the first to receive the Sinopharm vaccine as part of the campaign.

Some 43,491 people in Peru have died of COVID-19, according to official data. The country is facing a second wave of infections, with saturated hospitals and a shortage of medical equipment.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.